Analyze latest trends in small molecule drug discovery. Combines web search, PubMed, and industry news to identify emerging therapeutic targets, modalities, and technologies. Provides data-driven trend analysis.
Help users understand the latest trends in small molecule drug discovery by:
Before searching, identify:
Search in parallel:
Industry News (Priority 1)
Scientific Literature
Clinical Trials
Group findings into categories:
For each trend:
## 🔬 Latest Trends in [Topic] (2025)
### 📈 Top 3 Emerging Trends
#### 1. [Trend Name]
**What**: One-line description
**Why it matters**: Impact statement
**Key examples**:
- Example 1 (Source: X)
- Example 2 (Source: Y)
**Companies/Groups**: A, B, C
#### 2. [Trend Name]
...
### 🎯 Hot Targets
| Target | Indication | Why Hot | Key Companies |
|--------|------------|---------|---------------|
| ... | ... | ... | ... |
### 💊 Modality Trends
- **PROTACs**: [status and examples]
- **Molecular glues**: [status and examples]
- **Covalent inhibitors**: [status and examples]
### 📚 Key Recent Papers
1. Title (Journal, Date) - One-line significance
2. ...
### 💡 Bottom Line
2-3 sentences summarizing the most important insight
"[topic] drug discovery 2025 trends"
"[topic] FDA approval 2024 2025"
"[topic] clinical trial results 2025"
"[modality] breakthrough 2025"
"[topic] AND (2024[dp] OR 2025[dp]) AND review[pt]"
"[topic] AND clinical trial[pt] AND 2024[dp]"
| Topic | Key Search Terms |
|---|---|
| Oncology | KRAS, EGFR, ADC, bispecific, IO combinations |
| Neurology | Alzheimer, Parkinson, ALS, neuroinflammation |
| Autoimmune | JAK, TYK2, IL-17, TNF, BTK |
| Metabolic | GLP-1, GIP, amylin, NASH, obesity |
| Modalities | PROTAC, molecular glue, covalent, macrocycle, peptide |
Before finalizing response, verify:
❌ Don't:
✅ Do:
| User Question | Key Focus |
|---|---|
| "newest trends in small molecule drug discovery" | Broad: AI, PROTACs, covalent, targets |
| "what's hot in oncology small molecules?" | KRAS inhibitors, ADCs, KRAS G12C, etc. |
| "latest in PROTAC technology" | PROTAC-specific: E3 ligases, clinical trials |
| "emerging targets for Alzheimer's" | Neuro-specific: amyloid, tau, inflammation |